Register to download your application note today:
Assess virus neutralization with a rapid, HTS-friendly assay
The worldwide COVID-19 pandemic caused by the SARS-CoV-2 virus has necessitated the fast-tracked development of many research tools for understanding this virus’s pathogenesis, as well as vaccine discovery and development. Discover how you can achieve:
- Rapid, easy assay setup with an ELISA workflow
- Identify neutralizing antibodies without BSL-3 or cell culture
- Results consistent with data from plaque reduction neutralization test.